QL1203 In Combination With Chemotherapy for Metastatic Colorectal Cancer to Determine Efficacy and Safety
Clinical trial NCT04233151 · UNKNOWN
Trial details
- NCT number
- NCT04233151
- Sponsor
- Qilu Pharmaceutical Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-01-20
- Primary completion
- 2024-12-31
- Enrollment
- 590
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.